Nrg Therapeutics Announces £16 Million Series A To Advance Mitochondrial Therapeutics For Parkinson's And Als
Amount Raised
£16 Million
Round Type
Series A
StevenageBiotechnologyHealth CareTherapeuticsDescription
NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, today announced the closing of a £16 million Series A financing, led by Omega Funds and joined by additional new investor Brandon Capital and founding investor the Parkinson's Virtual Biotech. In connection with the financing, Omega Funds Managing Director Claudio Nessi and Partner Francesco Draetta, as well as Brandon Capital Partner Jonathan Tobin, have joined the company's Board of Directors.
Quick answer
NRG Therapeutics raised £16 Million in a Series A round, dated November 9, 2022. NRG Therapeutics is based in Stevenage, England, United Kingdom.
- How much did NRG Therapeutics raise?
- NRG Therapeutics raised £16 Million in a Series A round on November 9, 2022.
- What does NRG Therapeutics do?
- NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and..
- Where is NRG Therapeutics based and how big is it?
- NRG Therapeutics is based in Stevenage, England, United Kingdom.
- Who are the decision-makers at NRG Therapeutics?
- Fundz holds 1 contact at NRG Therapeutics, including the CEO . Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as NRG Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- GenSight Biologics raised $13M (Convertible Note) on December 23, 2022.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- QurAlis raised $60M on December 20, 2022.
- Gallant raised $25M on December 15, 2022.
- Alpha-9 Theranostics raised $75M (Series B) on December 14, 2022.
- STORM Therapeutics raised $30M (Series B) on December 14, 2022.
Who to call at NRG Therapeutics, and when
A new round usually means NRG Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NRG Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NRG Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NRG Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NRG Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNRG Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.